FDA — authorised 6 April 2011
- Application: NDA022399
- Marketing authorisation holder: AZURITY
- Status: supplemented
FDA authorised Horizant on 6 April 2011
Yes. FDA authorised it on 6 April 2011; FDA has authorised it.
AZURITY holds the US marketing authorisation.